Selenoprotein synthesis and side-effects of statins
- 1 March 2004
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 363 (9412) , 892-894
- https://doi.org/10.1016/s0140-6736(04)15739-5
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Statin-Associated MyopathyJAMA, 2003
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002
- Muscular Side Effects of StatinsJournal of Cardiovascular Pharmacology, 2002
- Cholesterol and Alzheimer's diseaseBiochemical Society Transactions, 2002
- Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26‐week randomized, placebo‐controlled, double‐blind trialAnnals of Neurology, 2002
- FDA Adverse Event Reports on Statin-Associated RhabdomyolysisAnnals of Pharmacotherapy, 2002
- Myopathy and rhabdomyolysis with lipid-lowering drugsToxicology Letters, 2002
- Statins and peripheral neuropathy.European Journal of Clinical Pharmacology, 1999
- Benefits and Risks of HMG-CoA Reductase Inhibitors in the Prevention of Coronary Heart Disease A ReappraisalDrug Safety, 1996
- Peripheral neuropathy associated with simvastatin.Journal of Neurology, Neurosurgery & Psychiatry, 1995